Park Ha Biological Director Resigns
Ticker: BYAH · Form: 6-K · Filed: Aug 25, 2025 · CIK: 1986247
Sentiment: neutral
Topics: director-resignation, governance
TL;DR
Park Ha Bio director Da Yang out, effective Aug 25. No drama cited.
AI Summary
Park Ha Biological Technology Co., Ltd. announced on August 25, 2025, that Mr. Da Yang has resigned as an independent director, effective immediately. The resignation was not due to any disagreements with the company's operations.
Why It Matters
A director's resignation can signal internal changes or governance shifts within a company, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a director's resignation without any indication of underlying issues.
Key Players & Entities
- Park Ha Biological Technology Co., Ltd. (company) — Registrant
- Da Yang (person) — Resigning Independent Director
- August 25, 2025 (date) — Date of resignation and effective date
FAQ
Who is Park Ha Biological Technology Co., Ltd.?
Park Ha Biological Technology Co., Ltd. is a company operating in the SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS industry, with its principal executive offices located in Wuxi, China.
What is the purpose of this 6-K filing?
This 6-K filing is a Report of Foreign Private Issuer for the month of August 2025, providing information to the SEC.
When was the resignation effective?
The resignation of Mr. Da Yang was effective August 25, 2025.
Were there any disagreements leading to the resignation?
No, the filing explicitly states that Mr. Da Yang's resignation was not a result of any disagreement with the Company's operations.
What is the company's fiscal year end?
The company's fiscal year ends on October 31st.
Filing Stats: 213 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2025-08-25 10:33:53
Filing Documents
- ea025446602-6k_parkha.htm (6-K) — 9KB
- 0001213900-25-080181.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Park Ha Biological Technology Co., Ltd. Date: August 25, 2025 By: /s/ Xiaoqiu Zhang Name: Xiaoqiu Zhang Title: Chief Executive Officer, Chairperson of the Board of Directors 2